Sputum cell counts and FeNO levels in patients treated with anti-IgE and anti-IL-5 /IL-5R: Evidence for a dissociation between sputum eosinophil counts and FeNO levels

被引:0
|
作者
Sabbe, Mare [1 ]
Schleich, Florence [1 ]
Bougard, Nicolas [1 ]
Moermans, Catherine [1 ]
Henquet, Monique [1 ]
Guissard, Francoise [1 ]
Sanschez, Carole [1 ]
Paulus, Virginie [1 ]
Louis, Renaud [1 ]
机构
[1] CHU Iiege, Liege, Belgium
关键词
D O I
10.1183/13993003.congress-2023.PA989
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
引用
收藏
页数:2
相关论文
共 25 条
  • [21] Comparison of Long-term Response and Remission to Omalizumab and Anti-IL-5/IL-5R Using Different Criteria in a Real-life Cohort of Severe Asthma Patients
    Valverde-Monge, Marcela
    Sanchez-Carrasco, Patricia
    Betancor, Diana
    Barroso, Blanca
    Rodrigo-Munoz, Jose Manuel
    Mahillo-Fernandez, Ignacio
    Arismendi, Ebymar
    Bobolea, Irina
    Cardaba, Blanca
    Cruz, Maria Jesus
    Del Pozo, Victoria
    Dominguez-Ortega, Javier
    Gonzalez-Barcala, Francisco Javier
    Olaguibel, Jose Maria
    Luna-Porta, Juan Alberto
    Martinez-Rivera, Carlos
    Mullol, Joaquim
    Munoz, Xavier
    Peleteiro-Pedraza, Lorena
    Valles, Cesar Picado
    Plaza, Vicente
    Quirce, Santiago
    Rial, Manuel Jorge
    Soto-Retes, Lorena
    Valero, Antonio
    Sastre, Joaquin
    ARCHIVOS DE BRONCONEUMOLOGIA, 2024, 60 (01): : 23 - 32
  • [22] Late Breaking Abstract- Comparative Effectiveness of Anti-IL5/5R Versus Anti-IgE in Patients Eligible for Both (FIRE)
    Ali, Nasloon
    Lyu, Juntao
    Newell, Anthony
    Sadatsafavi, Mohsen
    Tran, Trung N.
    Price, David B.
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [23] A FENO-BASED STRATEGY TO GUIDE ORAL CORTICOSTEROID INITIATION IN PATIENTS WITH SEVERE ASTHMA EXPERIENCING AN EXACERBATION WHILST ON TREATMENT WITH ANTI-IL5/5R THERAPY
    Lam, J. L.
    Hearn, A. P.
    Thomson, L. A.
    Green, L. M.
    Fernandes, M.
    Roxas, C.
    D'Ancona, G.
    Dhariwal, I.
    Nanzer, A. M.
    Jackson, D. J.
    THORAX, 2022, 77 : A87 - A87
  • [24] Effects of anti-IL5 biological treatments on blood IgE levels in severe asthmatic patients: A real-life multicentre study (BIONIGE)
    Contoli, Marco
    Santus, Pierachille
    Menzella, Francesco
    Rocchi, Cindy
    Radovanovic, Dejan
    Baraldi, Federico
    Martelli, Chiara
    Casanova, Serena
    Barbetta, Carlo
    Micheletto, Claudio
    Scichilone, Nicola
    Beghe, Bianca
    Carpagnano, Elisiana
    Papi, Alberto
    CLINICAL AND TRANSLATIONAL ALLERGY, 2022, 12 (04)
  • [25] Clinical Remission Criteria and Serum Levels of Type 2 Inflammation Mediators during 24 Weeks of Treatment with the Anti-IL-5 Drug Mepolizumab in Patients with T2-High Severe Asthma
    Palacionyte, Jolita
    Januskevicius, Andrius
    Vasyle, Egle
    Rimkunas, Airidas
    Miliauskas, Skaidrius
    Malakauskas, Kestutis
    DIAGNOSTICS, 2024, 14 (13)